Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Deborah, Sage"'
Autor:
Deborah Sage, Carla Rosser
Publikováno v:
International Journal of Immunogenetics. 48:385-402
The avoidance of antibody-mediated rejection (AMR) attributed to human leucocyte antigen (HLA) antibody incompatibility remains an essential function of clinical Histocompatibility and Immunogenetics (H&I) laboratories who are supporting solid organ
Autor:
Delordson Kallon, Judith C. W. Marsh, Cristina Navarrete, Laura Pankhurst, Ana Mora, Ghulam J. Mufti, Deborah Sage, Renate Hodge, Collette Pigden, Charlotte Llewelyn, Emma Laing, Kay Harding, Joanne Brown, Louise L. Choo, Simon J. Stanworth, Adeline Z. Gilbertson, Aleksandar Mijovic, Alison J Deary, Colin J. Brown
Publikováno v:
Blood. 137:310-322
Platelet transfusion refractoriness results in adverse outcomes and increased health care costs. Managing refractoriness resulting from HLA alloimmunization necessitates the use of HLA antigen–matched platelets but requires a large platelet donor p
Publikováno v:
International journal of health care quality assurance. 28(1)
Purpose – The purpose of this paper is to measure family member satisfaction with the care provided in an Australian private intensive care unit (ICU) at two time points separated by two years. The study was part of a quality improvement process fo
Publikováno v:
Transfusion Medicine. 15:481-485
Transfusion-associated graft-vs.-host disease (TA-GvHD) can occur following transfusion of blood products containing immunocompetent lymphocytes, usually from HLA homozygous donors, into immunocompromised patients sharing one HLA haplotype with the d
Autor:
Judith C. W. Marsh, Sarah E. Ball, Vikas Gupta, Mylene Freires, Deborah Sage, Edward C. Gordon-Smith, Miguel Ortín
Publikováno v:
Bone Marrow Transplantation. 35:467-471
Graft failure, regimen-related toxicity and graft-versus-host disease (GVHD) are the critical barriers to unrelated donor transplants for aplastic anaemia (AA). We investigated the use of a novel conditioning regimen consisting of alemtuzumab (humani
Autor:
Deborah Sage, Matthew Turner, Robert Whittle, Justin John, Hardev Pandha, Lindsay Birchall, Angus G. Dalgleish, Edit Kovalcsik
Publikováno v:
Melanoma Research. 14:463-471
Tumour cells are able to evade the immune system by using several 'escape mechanisms'. Downregulation of molecules involved in the processing and presentation of self-antigens has been reported. However, these adaptations have not been compared in me
Publikováno v:
Transfusion. 41:1421-1425
BACKGROUND: Transfusion-related acute lung injury (TRALI) is a rare condition that is commonly associated with the transfusion of donor plasma containing WBC antibodies. Biologically active lipids that accumulate during storage of RBCs and platelets
Autor:
Deborah Sage
Publikováno v:
Journal of clinical pathology. 63(3)
Haematopoietic stem cell transplantation (HSCT) is now viewed as an effective treatment modality for a wide and varied number of diseases including both malignant and non-malignant haematological diseases, bone marrow failures, inherited immunodefici
Autor:
D Turner, S Wiltshire, Judith C. W. Marsh, Parameswaran Anoop, Deborah Sage, Preeti Datta-Nemdharry, L O'Regan, Edward C. Gordon-Smith, M S Islam
Publikováno v:
Bone marrow transplantation. 45(5)
The precise effects of CD34+ cell dose on the outcome of allogeneic transplantation for aplastic anaemia (AA) are not known. Previous studies have used the total mononuclear cell count to quantify stem cell dose. We evaluated the effects of CD34+ cel
Autor:
Deborah Sage, Judith C. W. Marsh, D Turner, Pamela Kangasabapathy, Jennifer A. Tooze, Carol Brooker, Vikas Gupta, Qi-long Yi
Publikováno v:
British journal of haematology. 134(1)
The outcome of 81 adult aplastic anaemia patients who had successful cytogenetics at diagnosis and received immunosuppressive therapy was evaluated. Ten patients had an abnormal karyotype, six of which had a trisomy. Four of five evaluable patients w